Home
About
Pricing
Log In
Back
NTLA
Asset Logo

Intellia Therapeutics Inc.

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-5.50%
Annual Growth

5 years average annual capital growth

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Intellia Therapeutics, Inc. is a clinical-stage gene editing company focused on developing medicine with CRISPR-based therapies. CRISPR is a gene editing technology which is also sometimes referred to as CRISPR/Cas or CRISPR/Cas9 when referring to the use of CRISPR technology with the Cas9 enzyme. Its in vivo product candidates address genetic diseases by deploying its technologies, including CRISPR/Cas9 delivered by LNPs, as the therapy for diseases with high unmet need. Its lead in vivo product candidates, nexiguran ziclumeran (nex-z or NTLA-2001) for the treatment of transthyretin (ATTR) amyloidosis and NTLA-2002 for the treatment of hereditary angioedema (HAE), are the first CRISPR-based therapy candidates to be administered systemically, via intravenous (IV) infusion, for precision editing of a gene in a target tissue in humans. For its ex vivo product candidates, it applies its technologies to create engineered cell therapies to address immuno-oncology and autoimmune diseases.

📈 Performance

Price History*

-35.92%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$14.24

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in NTLA

0

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

13 weeks

💵 Average investment amount

$76

Last time a customer invested in NTLA

237 days
NTLA investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in NTLA also invest in...

Invesco QQQ Trust Series 1

QQQ

🙌 Performance (5Yr p.a)

23.71%

📊 Share price

$563.81 USD

📈 HIGH PRICE GROWTH

Find Out More

🙌 Performance (5Yr p.a)

29.91%

📊 Share price

$505.87 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

18.76%

📊 Share price

$1,120.37 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

591.52%

📊 Share price

$228.29 USD

🙌 Performance (5Yr p.a)

317.19%

📊 Share price

$170.78 USD

📈 HIGH PRICE GROWTH

Want more shares? Try these...

🙌 Performance (5Yr p.a)

46.50%

📊 Share price

$74.38 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

-6.79%

📊 Share price

$1.46 USD
Compare
Add to watchlist